Celgene

Developer of therapies for treating cancer and inflammatory diseases

placeSummit, New Jersey, United States calendar_todayFounded 1986 groups4,891 employees language celgene.com

Registered entities

Innovation

583 patent families (339 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing, Operations & transport; filing pace slowing. Cited 88,450 times.

YearFilings
2015106
2016118
2017127
2018128
2019113
2020111
2021122
2022123
2023122
202498
202590
202630

Investor mix

14 investors on record.

Investor typeCountShare
Venture capital536%
Private equity321%
Bank & private debt17%
Other / undisclosed536%
Coming soon